DNA methylation profiles of the brain - derived neurotrophic factor (BDNF) gene as a potent
diagnostic biomarker in major depression
Not exact matches
Related Articles: Merck's Keytruda held back by docs who don't want to wait for
diagnostics Bristol's Opdivo - Yervoy combo ups response rates
in first - line lung cancer patients Roche's Tecentriq bursts onto immuno - oncology scene, with Merck and BMS
in its sights Bristol - Myers» new Opdivo ad touts
biomarker advantage over Merck's Keytruda Merck's Keytruda lines up its survival data for stepped - up battle with BMS» Opdivo
ProAxsis is a
diagnostics company based
in Northern Ireland, developing a range of products to identify active protease
biomarkers of diseases.
The members of the initiative hope to improve early detection of cancer by making an impact
in a variety of areas, including doing epidemiologic studies on risk factors, developing new and improved methods of
diagnostic imaging, discovering and verifying new
biomarkers as indicators of cancer, and developing new technologies to aid early detection.
«Researchers isolate novel urinary
biomarkers that may indicate adrenal cancer: A quartet of metabolites found
in urine samples may help solve
diagnostic and treatment dilemmas associated with clinically silent adrenal masses.»
The combination of longitudinal
biomarkers improves
diagnostic accuracy compared with use of a single marker and provides a powerful tool
in personalized medicine.
The information potential held by miRNAs, combined with the fact that they are stable
in serum and plasma, has led to a rapidly growing interest
in using miRNAs
in blood as
diagnostic and prognostic
biomarkers.
His research focuses predominantly on oncology molecular
diagnostics, particularly the source and utility of miRNA
biomarkers in blood, and the development of innovative molecular
diagnostics for the identification of mutations that can guide therapeutic decision - making.
«Our group, which includes more than 180 myeloma researchers worldwide, has updated the definition of multiple myeloma for
diagnostic purposes to include validated
biomarkers in addition to the current clinical symptoms used for diagnosis which include, elevated blood calcium levels, kidney failure, anemia and bone lesions,» said lead author S. Vincent Rajkumar, M.D. a hematologist at Mayo Clinic.
«Using
biomarkers for cancer detection is an important advance
in managing women with dense breasts and navigating many
diagnostic challenges.
However, single
biomarkers are biologically implausible as a
diagnostic test for complex diseases like CFS and are likely to perform poorly
in larger populations.
The identification of
diagnostic tests or
biomarkers that predict progression to active TB disease would greatly enhance TB control efforts
in the United States and globally and allow physicians and public health officials to focus efforts on treatment of latent TB infection of those at greatest risk of progression to active, transmissible and potentially fatal disease.
«Lastly, the technique we have pioneered will likely be a valuable tool for scientists and clinicians studying the biology of complex nanoparticle populations,» Dr. Zhang said, «and may aid
in the development of
diagnostic tests using them as
biomarkers.»
Our faculty pursues research
in DNA analysis, GIS, disease
diagnostics and other
biomarkers, ecological anthropology, forensic anthropology, fossil excavation, modern Mayan cultures, Global and One Health, and both historic and prehistoric archaeology.
The Policies and Guidelines, ratified by IRDiRC members for implementation
in their respective rare disease research programs, are structured around 11 major topics: data sharing and standards, ontologies,
diagnostics,
biomarkers, patient registries, biobanks, natural histories, therapeutics, model systems, publication and intellectual property, and communications.
A recent study reported that two oxysterol species, 15HC and 15KC, were increased more than three-fold
in the blood of multiple sclerosis patients, suggesting a potential use for these oxysterols as
diagnostic biomarkers.
And we are now taking advantage of the different skills that we have
in the consortium to try to interpret these and see how they evaluate the potential to be a
biomarker of either progression or an early
diagnostic tool.
«Having been a partner with Roche for several years, we have every confidence that the combination of our own expertise and Roche's considerable capabilities
in clinical development,
biomarkers and
diagnostics will help us maximize the potential for this programme,» commented Stuart W. Peltz, Ph.D., President and CEO of PTC.
According to a release from Dr. Hassan Dihazi, editor
in chief, the journal covers all areas of proteomics including basic proteomic research; structural, functional, property, and interaction analysis of cellular systems, organelles, and protein complexes; and protein expression profiling for the discovery and validation of
diagnostic and prognostic disease
biomarkers.
RBM's initial molecular
diagnostic test, VeriPsychTM, is a blood - based test that aids
in the confirmation of diagnosis of recent - onset schizophrenia by evaluating a proprietary set of 51
biomarkers.
Our LabPMM labs
in the USA, Europe, and Asia offer an ever - expanding menu focused on
biomarkers that have demonstrated clinical utility to support patient stratification & enrollment
in clinical trials, companion
diagnostic development, and optimized treatment for patients.
Harshini Mukundan, of Los Alamos» Nuclear and Radiochemistry group made critical breakthroughs
in optical detection techniques of diseases such as tuberculosis, allowing rapid detection
in the field, and discovered an entirely new class of
diagnostic molecules that led to chemical recognition of various
biomarkers.
ACD technology is used
in proprietary
diagnostic tests for cancer management and to validate
biomarkers for targeted therapeutic development.
SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global company with decades of experience providing internationally standardized clonality and
biomarker testing solutions for the fields of oncology, personalized molecular
diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric antigen receptor T - cells (CAR - T) and engineered T - cell receptors
in peripheral blood of subjects
in support of immuno - therapeutic drug development and treatment regimen development for both hematologic and solid tumors.
View the video and see where Olink Proteomics is today (at the forefront of targeted protein
biomarker discovery), and where we see our future,
in the development of precision
diagnostics and the realization of precision medicine.
Biomarkers included are available to order as individual tests, or as a comprehensive profile to help provide simultaneous
diagnostic information about multiple conditions
in a single blood draw.
If cancer is actually suspected there is also a
Biomarker screen that can aid
in a
diagnostic workup and therapeutic monitoring.